CURAXIS PHARMACEUTICAL CORP Operating Expenses
CURAXIS PHARMACEUTICAL CORP reported Operating Expenses of $345.00 thousand for the 3-month period ending 2012-03-31, per its 10-Q filed 2012-05-14.
Discontinued › Operating Expenses
us-gaap:OperatingExpenses · last filed 2012-05-14
- CURAXIS PHARMACEUTICAL CORP operating expenses for the quarter ending 2012-03-31 was $345.00K, a 45.24% decline year-over-year.
- CURAXIS PHARMACEUTICAL CORP operating expenses for the quarter ending 2011-12-31 was $462.00K, a 20.94% increase year-over-year.
- CURAXIS PHARMACEUTICAL CORP operating expenses for the quarter ending 2011-09-30 was $360.00K, a 38.78% decline year-over-year.
- CURAXIS PHARMACEUTICAL CORP operating expenses for the quarter ending 2011-06-30 was $470.00K, a 8.05% increase year-over-year.
- CURAXIS PHARMACEUTICAL CORP operating expenses for fiscal 2011 was $1.92M, a 0.77% decline from fiscal 2010.
- CURAXIS PHARMACEUTICAL CORP operating expenses for fiscal 2010 was $1.94M.
| Period end | Operating Expenses 3 month | Operating Expenses 6 month | Operating Expenses 9 month | Operating Expenses 12 month | Operating Expenses 41 month | Operating Expenses 127 month | Operating Expenses 130 month | Operating Expenses 133 month |
|---|---|---|---|---|---|---|---|---|
| 2012-03-31 | $345.00K 10-Q · filed 2012-05-14 | $807.00K derived: sum of 2 quarters · filed 2012-05-14 | $1.17M derived: sum of 3 quarters · filed 2012-05-14 | $1.64M derived: sum of 4 quarters · filed 2012-05-14 | $97.40M 10-Q · filed 2012-05-14 | |||
| 2011-12-31 | $462.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-29 | $822.00K derived: sum of 2 quarters · filed 2012-03-29 | $1.29M derived: sum of 3 quarters · filed 2012-03-29 | $1.92M 10-K · filed 2012-03-29 | $97.05M 10-K · filed 2012-03-29 | |||
| 2011-09-30 | $360.00K 10-Q · filed 2011-11-10 | $830.00K derived: sum of 2 quarters · filed 2011-11-10 | $1.46M 10-Q · filed 2011-11-10 | $1.84M derived: sum of 4 quarters · filed 2012-05-14 | $96.59M 10-Q · filed 2011-11-10 | |||
| 2011-06-30 | $470.00K 10-Q · filed 2011-08-12 | $1.10M 10-Q · filed 2011-08-12 | $1.48M derived: sum of 3 quarters · filed 2012-05-14 | $2.07M derived: sum of 4 quarters · filed 2012-05-14 | $96.23M 10-Q · filed 2011-08-12 | |||
| 2011-03-31 | $630.00K 10-Q · filed 2012-05-14 | $1.01M derived: sum of 2 quarters · filed 2012-05-14 | $1.60M derived: sum of 3 quarters · filed 2012-05-14 | $2.04M derived: sum of 4 quarters · filed 2012-05-14 | ||||
| 2010-12-31 | $382.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-29 | $970.00K derived: sum of 2 quarters · filed 2012-03-29 | $1.41M derived: sum of 3 quarters · filed 2012-03-29 | $1.94M 10-K · filed 2012-03-29 | ||||
| 2010-09-30 | $588.00K 10-Q · filed 2011-11-10 | $1.02M derived: sum of 2 quarters · filed 2011-11-10 | $1.55M 10-Q · filed 2011-11-10 | |||||
| 2010-06-30 | $435.00K 10-Q · filed 2011-08-12 | $967.00K 10-Q · filed 2011-08-12 |